32. Rebuilding the Global Antibiotic Pipeline: Evolve or Die
Thursday, October 8, 2015: 10:30 AM-12:00 PM
Room: 6--AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • define the bottlenecks that have limited the discovery and development of antimicrobials
  • discuss novel and multidisciplinary approaches that are being used to reinvigorate the antimicrobial pipeline
  • recognize opportunities for participation in the antimicrobial discovery and development process
  • assess the value of antibiotics as therapeutic agents

Target Audience: Scientists, Researchers, Pharmacists, Investigators, Infectious diseases physicians, Clinicians, Academicians

Tracks: Investigative ID, Adult ID

Moderators:  Sujata M. Bhavnani, PharmD, MS, Institute for Clinical Pharmacodynamics and David Andes, MD, FIDSA, University of Wisconsin

10:50 AM
New Regulatory Pathways
David Shlaes, MD, PhD, FIDSA

11:10 AM
How Can PK-PD Help?
Sujata M. Bhavnani, PharmD, MS

CME Credits: No CME credit is offered for this session.

ACPE Credits: ACPE 1.50 knowledge-based contact hours (0.150 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-151-L04-P


S. M. Bhavnani, Various: Research Contractor , Research support

D. Andes, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.